Skip to content

ALSERES PHARMACEUTICALS INC /DE: filings

Every ALSERES PHARMACEUTICALS INC /DE annual and quarterly report in the SEC record with the published financial measures it tagged, 13 filings, each linked to its SEC index.

Filing record ends 2014-08-14

The latest filing in this captured record is a 10-Q filed 2014-08-14. No later filing is in the SEC companyfacts record captured on 2026-09-23. ALSERES PHARMACEUTICALS INC /DE may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2014-08-14fiscal Q2 201421560001193125-14-309279
10-Q2014-05-23fiscal Q1 201421420001193125-14-211193
10-K2014-04-10fiscal FY 201328760001193125-14-137904
10-Q2013-11-14fiscal Q3 201326760001193125-13-442102
10-Q2013-08-09fiscal Q2 201327800001193125-13-328326
10-Q2013-05-17fiscal Q1 201326610001193125-13-225865
10-K2013-04-01fiscal FY 201228760001193125-13-136073
10-Q2012-11-14fiscal Q3 201226750001193125-12-468653
10-Q2012-08-13fiscal Q2 201225720001193125-12-350936
10-Q2012-05-11fiscal Q1 201226590001193125-12-228157
10-K2012-03-29fiscal FY 201131810001193125-12-139930
10-Q2011-11-10fiscal Q3 201128830000950123-11-097396
10-Q2011-08-11fiscal Q2 201124660000950123-11-075930

Inspect the source

Entity
ALSERES PHARMACEUTICALS INC /DE / CIK 0000094784
Captured
SEC response SHA-256
67d3a858977a656ee0b8fc871dfd3b585faeffaf3905b0040597f843e1ed1a76

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000094784.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))